Veterinary Drug Market
Veterinary Drug Market by () by () , by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa): Global Market Assessment, 2021 – 2028
The global Veterinary Drug market was valued at USD 24.31 Billion in 2020 and is projected to reach USD 40.75 Billion by 2028, growing at a CAGR of 6.67%% from 2021 to 2028.
|Historical Data (Actual Data)||2016-2020|
|Base Year Data||2020|
|Current Year Date||2021|
|Projected year data||2021-2028|
|Annual Market Size (2028)||40.75 Billion|
|Annual Market Size (2021)|
|CAGR (2021 - 2028)||6.67%%|
Overview and Description
Veterinary medicine is termed as any product used to treat various medical conditions in animals. For instance, veterinary medicine include drugs such as anti-infective drugs and parasiticides, which are administered orally in animals.
The global Veterinary Drug market is segmented based on products, applications, regions, and countries. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. All the segments have been analyzed based on present and future trends. The research study provides complete assessment of the market on the basis of competition, drivers, restraints, opportunities, trends, and industry-authenticated data. The market is estimated from 2016 to 2020 with forecast from 2021 to 2028.
COVID-19 Impact Analysis
COVID-19 pandemic led to government of numerous countries across the globe to impose strict lockdown restrictions during the preliminary stages. In 2021, numerous countries faced the adverse effects of the pandemic due to the outbreak of second wave, which also led governments to again impose lockdown measures. Business shutdowns, partial business operations, and travel restrictions have led to challenges in supply chain and in turn production. However, it is expected that reopening of trade activities, the market will witness steady growth in the demand in the coming years. Impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends for all the regions and countries.
The report provides a completely separate chapter for COVID-19 Impact Analysis. This chapter includes:
o Impact Assessment of COVID-19 Pandemic
o Pre & Post COVID-19 Market Size
o Qualitative analysis on the short term & long term impact of COVID-19 on the market
o The analysis provides foremost strategies adopted by competitors to minimize the impact of the pandemic on their business activities and scope for future developments.
The surge in ownership of companion animals and adoption of animals is anticipated to augment the growth of the veterinary drug market over the forecast period.
The rise in livestock population across the globe is also expected to fuel the growth of the market during the forecast period.
The stringent regulatory approvals related to veterinary drugs and vaccines is expected to hamper the growth of the market over the forecast period.
Global Veterinary Drug Market Report Scope
|Market Size Provided for Years||2016-2028|
|Market Size Provided In Terms Of||Revenue & Volume|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Countries Covered||The U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, South East Asia, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Companies Covered||Ringpu Biology, Qingdao Yebio Bioengineering Co.Ltd, USP, ThermoFisher SCIENTIFIC, BVL, Meijing, Portland House Veterinary Group, Orion.|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis|
Regional Analysis: Preview
Based on region, the global Veterinary Drug market is segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America region led the market with the largest share in 2020. Some of the key countries contributing to the surge in the market are the U.S., U.K., Germany, France, China, India, Japan, and South Korea.
The market comprises of numerous small, medium, and large sized players spread across various geographies. Some of the main competitors in the global Veterinary Drug market are Ringpu Biology, Qingdao Yebio Bioengineering Co.Ltd, USP, ThermoFisher SCIENTIFIC, BVL, Meijing, Portland House Veterinary Group, Orion.. The report covers company market share analysis which gives a comprehensive overview of the main competitors in the market. In addition, the report also covers major strategies adopted by market players such as new product launch, acquisitions & mergers, partnerships, collaborations & joint ventures, research & development, and regional expansion. The study also covers the product portfolio of major companies operating in the market.
Market Size, 2021 (USD Billion)
Global Veterinary Drug Market: Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of MEA
Key Highlights – Global Veterinary Drug Market
- Global Veterinary Drug Market is projected to reach USD 40.75 Billion by 2028
- North America held the highest share of the Veterinary Drug market
- Antifungal drugs held the largest share of the product segment in the Veterinary Drug market
- Commercial held the major share of the application segment in the Veterinary Drug market
Frequently Asked Questions
the global demand for Veterinary Drug
in terms of revenue?
The global Veterinary Drug valued at 24.31 Billion in 2020 and is expected to reach 40.75 Billion in 2028 growing at a CAGR of 6.67%%
are the prominent players
in the market?
The prominent players in the market are Ringpu Biology, Qingdao Yebio Bioengineering Co.Ltd, USP, ThermoFisher SCIENTIFIC, BVL, Meijing, Portland House Veterinary Group, Orion..
At what CAGR is the market projected to grow within the forecast period?
The market is project to grow at a CAGR of 6.67%% between 2021 and 2028.
the driving factors
fueling the growth of the market.
The driving factors of the Veterinary Drug include
- The surge in ownership of companion animals and adoption of animals is anticipated to augment the growth of the veterinary drug market over the forecast period.
- The rise in livestock population across the globe is also expected to fuel the growth of the market during the forecast period.
region accounted for the
largest share in the market?
North America was the leading regional segment of the Veterinary Drug in 2020.